Laurie Klipfel – Diabetes Medications Part 2: Insulins
- Laurie Klipfel
- 2 Hours 8 Minutes
- Audio and Video
- Dec 26, 2017
Regardless of your setting you are caring for patients with diabetes that are prescribed insulin and as people are living longer, more eventually will need supplemental insulin. Insulin is vital for life, but can be dangerous or even fatal when administered incorrectly. It is vital that health care providers are familiar with optimum insulins, insulin doses and timing for the best outcomes. In this program Laurie Klipfel, RN, MSN, APN-BC, CDE, will provide you with the MUST know information you need to provide the best care to your patients.
|Manual (0.88 MB)||37 Pages||Available after Purchase|
- Function of Insulin
- Goals of Insulin Therapy
- Basal Bolus Administration
- Initial Dosing for Type 1 and Type 2
- Assessing Effectiveness
- Adjusting Doses to Improve Effectiveness
- Insulin Action Curves
- Concentrated Insulin
- Inhaled Insulin
Laurie Klipfel, RN, MSN, ANP-BC, CDE Related seminars and products: 7
Laurie Klipfel, RN, MSN, ANP-BC, CDE, has been a Certified Diabetes Educator for over 20 years and has managed several hospital ADA-recognized diabetes education programs; she is a Board Certified Adult Nurse Practitioner with a specialty in endocrinology and a certification in wound care. A member of the American Association of Diabetes Educators, Laurie is the past president of her local chapter. Laurie works at a large hospital in St. Louis, MO, serving the needs of patients with diabetes in both inpatient and outpatient settings.
Laurie is also a certified insulin pump trainer and has published articles on use of insulin pumps for hospitalized patients. Her practical experiences, supported by clinical knowledge, provide a blend of information on how to treat diabetes today. Her goal is to provide the current strategies and treatments you need to improve the outcomes of your patients.
Financial: Laurie Klipfel receives a speaking honorarium from PESI, Inc.
Nonfinancial: Laurie Klipfel has no relevant nonfinancial relationship to disclose.